Addressing the
#1 Cause of Death After a Heart Attack

We’re Reinventing the Standard of Care in Mechanical Circulatory Support

THE PROBLEM


A serious, life-threatening condition—Cardiogenic Shock

There remains a significant unmet clinical need

  • #1 cause of death after a heart attack

  • Key risk for patients with Acute Decompensated Heart Failure

Cardiogenic shock has 40%-60% mortality rate

Mechanical circulatory support (MCS) is required when the heart is unable to pump sufficient blood & oxygen to the body, resulting in end-organ failure

Significant complication risks with the current standard of care

Major bleeding

Sepsis

Infection

Vascular injury

Hemolysis

Arterial blockages leading to limb ischemia or stroke

OUR SOLUTION


Introducing Percutaneous Synchronized Cardiac Assist (PSCA)

Our implant uses an inflatable balloon to apply ECG-synchronized left ventricular compression, without entering the heart or bloodstream

How it works

Highly differentiated technology

This novel implant and its extravascular placement (using a simple, less invasive procedure) is designed to avoid many of the risks and complications of current, temporary MCS devices

Extravascular/extracardiac


Less invasive and avoids hemolysis, stroke

No contrast imaging


Reduces contrast-induced nephropathy

No anticoagulants


Minimizes bleeding

THE OPPORTUNITY

Platform play with multi-
billion $ global markets*

$18B

Acute Market | Cardiogenic Shock


$9B

Chronic Market | Heart Failure

Experienced Leadership Team

100+ years of combined experience successfully advancing innovation in leading MedTech companies

  • Gerardo Noriega

    President/CEO

  • Albert Chin, MD

    Chief Innovation Officer

  • Jim Heslin

    IP Counsel

  • Susan Osborne

    VP Regulatory, Clinical and Quality

  • Bezhad Behrooz

    VP R&D and Operations

  • Ann Benham

    Head of Marketing

World-Renowned Clinical Advisory Board

  • Daniel Burkhoff, MD, Ph.D

    Director of Heart Failure,
    Hemodynamics & MCS Cardiovascular
    Research Foundation

  • Prof. Petr Neužil, MD

    Chairman, Dept of Cardiology, Na Homolce Hospital, Prague, CZ

  • Mitchell Krukoff, MD

    Director, Cardiovascular Devices Unit, Duke University Medical Center

  • Kendrick Shunk, MD

    Chief Interventional Cardiology UCSF/SFVA

  • Dan Meyer, MD

    Chief of Cardiac Transplantation,
    Baylor Scott & White Hospital Dallas

  • William O'Neill, MD

    Medical Director of the Center for Structural Heart Disease, Henry Ford Hospital

  • Henry Hsia, MD

    Chief of VT and Electrophysiology at UCSF, FACC,
    Professor of Medicine